Immune response to the severe acute respiratory syndrome coronavirus 2 vaccines: Is it sustained in the diabetes population?

Rouka, Erasmia; Livanou, Eleni; Sinis, Sotirios; Dimeas, Ilias; Pantazopoulos, Ioannis; Papagiannis, Dimitrios; Malli, Foteini; Kotsiou, Ourania; Gourgoulianis, Konstantinos I

Rouka, Erasmia; Livanou, Eleni; Sinis, Sotirios; Dimeas, Ilias; Pantazopoulos, Ioannis; Papagiannis, Dimitrios; Malli, Foteini; Kotsiou, Ourania; Gourgoulianis, Konstantinos I.

Rouka E; Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Livanou E; Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Sinis S; Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Dimeas I; Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Pantazopoulos I; Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Papagiannis D; Faculty of Nursing, University of Thessaly, Larissa, Greece.
Malli F; Faculty of Nursing, University of Thessaly, Larissa, Greece.
Kotsiou O; Faculty of Nursing, University of Thessaly, Larissa, Greece.
Gourgoulianis KI; Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece.

J Diabetes Investig ; 13(8): 1461-1462, 2022 08.

Article in English | MEDLINE | ID: covidwho-1764965

Subject(s)

COVID-19; Diabetes Mellitus; Vaccines; COVID-19/prevention & control; Humans; Immunity; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Diabetes Mellitus / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Diabetes Investig Year: 2022 Document Type: Article Affiliation country: Jdi.13787

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google